Iranian firm secures US patent for nano-cocrystal curcumin tech
A nano-cocrystal curcumin invention developed by an Iranian knowledge-based company has been registered with the United States Patent and Trademark Office, with support from Iran’s Intellectual Property Management Center (IPMC), ISNA reported on Wednesday.
The invention has been commercialized with the technology already introduced to markets through three human-consumption products — oral lozenges, oral vials and beverages — and two animal products.
Nano-cocrystal curcumin represents a next-generation bioactive compound technology designed to enhance oral absorption of curcumin. The compound traditionally suffers from less than one percent oral absorption due to extremely low water solubility. The nano-cocrystal approach has increased this absorption rate by more than 100 times.
According to Iran’s Vice Presidency for Science and Technology, the technology integrates cocrystal and nanocrystal sciences to create a fully soluble and stable nano-dimensional form of curcumin.
The advancement enables incorporation of curcumin into diverse food and pharmaceutical formulations while reducing required dosage to less than one-tenth of existing market products, potentially delivering significant effects for joint pain, migraines and various cancers, vice presidency said.
Unique features of the technology include a more than 10,000-fold increase in water solubility, high stability under varied storage conditions, and the capacity to convert curcumin into a natural energizer, the vice presidency added.